PB Financial Corporation (PBNC)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	149	131	98	94	88	70
Market Cap Growth	21.85%	33.67%	4.47%	6.19%	26.35%	2.42%
Last Close Price	50.02	43.38	35.96	36.48	33.95	26.40
PE Ratio	8.16	8.28	7.04	6.58	8.99	10.27
PS Ratio	3.15	3.14	3.20	3.28	4.06	4.06
PB Ratio	1.07	0.98	1.12	1.39	1.35	1.20
P/FCF Ratio	-	8.00	6.63	6.25	8.22	9.77
P/OCF Ratio	-	7.70	6.52	6.23	8.17	9.54
Debt / Equity Ratio	0.45	0.45	0.96	1.51	0.91	1.18
Debt / FCF Ratio	-	3.69	5.67	6.80	5.52	9.61
Return on Equity (ROE)	-	15.32%	17.96%	21.49%	15.92%	12.15%
Return on Assets (ROA)	-	1.47%	1.52%	1.84%	1.52%	1.28%
Earnings Yield	12.33%	12.92%	14.21%	15.20%	11.12%	9.74%
FCF Yield	-	12.50%	15.08%	16.00%	12.16%	10.23%
Dividend Yield	4.64%	4.96%	5.17%	3.37%	2.97%	3.16%
Payout Ratio	-	41.04%	31.78%	19.27%	22.62%	27.05%
Buyback Yield / Dilution	-6.27%	-18.86%	-5.33%	-1.33%	-0.38%	-1.08%
Total Shareholder Return	-1.63%	-13.91%	-0.16%	2.04%	2.60%	2.08%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.